Swansea University

- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1920-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.swan.ac.uk
Clinical Trials
53
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (43 trials with phase data)• Click on a phase to view related trials
Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction.
- Conditions
- Pelvic-floor Disorders
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Swansea University
- Target Recruit Count
- 700
- Registration Number
- NCT06961513
- Locations
- 🇬🇧
Singleton Hospital, Swansea, United Kingdom
Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
- Conditions
- SleepAutism or Autistic TraitsADHD or ADHD Traits
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Swansea University
- Target Recruit Count
- 200
- Registration Number
- NCT06698588
- Locations
- 🇬🇧
FHMLS, Swansea, United Kingdom
Optimizing Older Adults' Home Space for Physical Activity
- Conditions
- Activity
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Swansea University
- Target Recruit Count
- 23
- Registration Number
- NCT06407557
- Locations
- 🇬🇧
Swansea University, Swansea, United Kingdom
Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension
- Conditions
- Hypertension
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Swansea University
- Target Recruit Count
- 45
- Registration Number
- NCT06335433
- Locations
- 🇬🇧
Swansea University, Swansea, Wales, United Kingdom
The Dose Response Effect of Isometric Handgrip Training Frequency on Blood Pressure in Normotensive Individuals
- Conditions
- Blood Pressure
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Swansea University
- Target Recruit Count
- 60
- Registration Number
- NCT06329804
- Locations
- 🇨🇳
National Taiwan Normal University, Taipei, Taiwan
🇬🇧Swansea University, Swansea, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
Psoriasis Drug Ustekinumab Shows Promise in Preserving Insulin Production in Young Type 1 Diabetes Patients
A clinical trial found that ustekinumab, a drug currently used for psoriasis, preserved insulin production in young type 1 diabetes patients, with C-peptide levels 49% higher after one year compared to placebo.